Hypercapnic respiratory failure in COPD patients: response to therapy

Chest. 2000 Jan;117(1):169-77. doi: 10.1378/chest.117.1.169.

Abstract

Introduction: The clinical course of patients with acute exacerbations of underlying COPD presenting with hypercapnic respiratory failure was reviewed.

Methods: This was a retrospective review of 138 episodes of hypercapnic respiratory failure (PaCO(2) > or = 50 mm Hg and pH < or = 7.35). Patients were admitted to the West Los Angeles VAMC Medical Intensive Care Unit between 1990 and 1994.

Results: Of the 138 hypercapnic episodes, 74 (54%) required intubation. Comparison was made with the 64 cases in which patients responded to medical therapy. Patients requiring intubation had a greater severity of illness, with a higher APACHE II (Acute Physiology and Chronic Health Evaluation II) score (18 +/- 5 vs 16 +/- 4; p < 0.01), higher WBC, higher serum BUN, and greater acidosis (pH, 7.26 +/- 0.07 vs 7.28 +/- 0.06; p = 0.08). Those with the most severe acidosis (pH < 7.20) had the highest intubation rate (70%) and shortest time to intubation (2 +/- 2 h), and they required the longest period of time to respond to medical therapy (69 +/- 60 h). With an initial pH of < 7.25, there was a consistently higher intubation rate. Conversely, those with an initial pH of 7.31 to 7. 35 were less likely to be intubated (45%), had a longer time to intubation (13 +/- 18 h), and had a more rapid response to medical therapy (30 +/- 18 h). Of those patients requiring intubation, most (78%) were intubated within 8 h of presentation, and the vast majority (93%) by 24 h. Of those patients responding to medical therapy, half (52%) recovered within 24 h and the vast majority (92%) recovered within 72 h.

Conclusions: This study provides a better characterization of the response to therapy of COPD patients with hypercapnic respiratory failure. This should be useful in limiting or omitting medical therapy in high-risk patients, thereby avoiding delays in intubation as well as providing a framework for continued therapy in those more likely to improve.

Publication types

  • Comparative Study

MeSH terms

  • APACHE
  • Acidosis, Respiratory / blood
  • Acidosis, Respiratory / etiology
  • Blood Urea Nitrogen
  • Female
  • Humans
  • Hypercapnia / blood
  • Hypercapnia / etiology*
  • Hypercapnia / mortality
  • Hypercapnia / therapy
  • Intensive Care Units
  • Intubation, Intratracheal
  • Lung Diseases, Obstructive / blood
  • Lung Diseases, Obstructive / complications*
  • Lung Diseases, Obstructive / mortality
  • Lung Diseases, Obstructive / therapy
  • Male
  • Respiration, Artificial
  • Respiratory Function Tests
  • Respiratory Insufficiency / blood
  • Respiratory Insufficiency / etiology*
  • Respiratory Insufficiency / mortality
  • Respiratory Insufficiency / therapy
  • Retrospective Studies
  • Survival Rate